Filter
687
Filtered Results: 687
Text search:
World
Health
Organization,
Regional
Office
for
the
Eastern
Mediterranen
Featured
Recommendations
98
New Publications
135
Language
Document type
No document type
234
Studies & Reports
179
Guidelines
129
Manuals
59
Strategic & Response Plan
35
Training Material
14
Fact sheets
11
Situation Updates
10
Resource Platforms
6
Infographics
6
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
61
Syria
22
Africa
17
Middle East and North Africa
15
Western and Central Europe
14
Somalia
10
Yemen
9
Ethiopia
6
Pakistan
6
Sudan
6
South–East Asia Region
6
Eastern Europe
6
Nigeria
5
Kenya
5
Latin America and the Carribbean
5
Sierra Leone
4
Liberia
4
Senegal
4
Iraq
4
Jordan
4
Afghanistan
4
Lebanon
4
Myanmar / Burma
4
Saudi Arabia
3
Ghana
3
Rwanda
3
Iran
3
Uganda
2
Philippines
2
India
2
Nepal
2
Turkey
2
Thailand
2
China
2
South Africa
2
Bangladesh
2
Ukraine
2
West and Central Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Asia
2
Venezuela
2
Burkina Faso
1
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Cameroon
1
Egypt
1
Tanzania
1
Cambodia
1
Benin
1
North Macedonia
1
Croatia
1
Ecuador
1
Greece
1
Libya
1
East and Southern Africa
1
Palestine
1
Albania
1
Djibouti
1
Russia
1
Qatar
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
96
Countries
85
Public Health
71
Women & Child Health
62
Key Resources
39
Capacity Building
16
Pharmacy & Technologies
15
Toolboxes
Mental Health
85
COVID-19
76
Planetary Health
46
Rapid Response
42
HIV
38
TB
38
Caregiver
30
NTDs
30
Conflict
29
Refugee
27
Global Health Education
27
AMR
27
Disability
25
NCDs
20
Pharmacy
19
Ebola
12
Polio
8
Cholera
6
Zika
6
Natural Hazards
5
Specific Hazards
4
Health Financing Toolbox
4
Typhoon
1
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to ... hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviours and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination.
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance ... resistant microorganisms, access to safe, effective antimicrobial medicines, control of the misuse of these medicines, awareness and understanding among the general public and effective infection prevention and control programmes.
School health programmes have been demonstrated to be the most cost-effective way to influence health behaviours in young people. ... purpose of this two-part handbook is to support schools as they seek to implement interventions aimed at reducing the main modifiable risk behaviours for noncommunicable diseases (NCDs) . The background provided in this Introduction handbook and the approaches and advice outlined in the Practical application handbook focuses on providing young people with the knowledge, attitudes, beliefs and life skills necessary for making informed decisions, and creating a healthy school environment that can reduce the risk of NCDs
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of ... disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The 2022 edition of the report is as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2022, 202 countries and territories with more than 99% of the world’s population and TB cases reported data
The risk communication and community engagement (RCCE) competency framework is a resource that details the essential behaviours and activities necessary f... effective communication and engagement with communities before, during and after public health emergencies. The purpose of this framework is to establish and promote a common understanding of behavioural competencies and how they should be applied for high-performing and community-centred health emergency programmes. It is intended to support the development of standardized training programmes, professional development and talent acquisition and to enhance the capabilities of public health professionals involved in RCCE. Its goal is to inform the establishment of a skilled, well-trained RCCE workforce that consistently understands and executes the necessary behaviours and activities required to conduct RCCE activities with competence and professionalism.
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of ... disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The World Health Organization’s comprehensive antenatal care (ANC) guideline WHO recommendatio...
The push to immunize all children against polio has been hampered by the ongoing crisis in the Syrian Arab Republic. WHO and UNICEF have appealed t...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduc...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, ... report documents early efforts of the World Health Organization (WHO) and participating countries to monitor antimicrobial consumption, describes the WHO global methodology for data collection, and highlights the challenges and future steps in monitoring antimicrobial consumption.
The updated List of Essential Diagnostics contains 46 general tests that can be used for routine patient care as well as for ... detection and diagnosis of a wide array of disease conditions, and 69 tests intended for the detection, diagnosis and monitoring of specific diseases.
The List is divided into two sections depending on the user and setting: one for community settings, which includes self-testing; and a second one for clinical laboratories, which can be general and specialized facilities.
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In ... last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and over 46 000 new fatalities were reported globally – an increase of 25% and 21%, respectively, compared to the previous 28 days. As of 1 January 2023, over 656 million confirmed cases and over 6.6 million deaths have been reported globally.
In this edition, we include:
The COVID-19 epidemiological update at the global and regional levels.
An update on the circulating SARS-CoV-2 variants of concern (VOCs) and Omicron subvariants under monitoring.
An update on hospitalizations and ICU admissions related to COVID-19.
GO pre-deployment training: participant handbook
recommended
This is a pre-deployment training, tailored specially to the Ebola outbreak in West Africa, offered to WHO personnel, consultants, and key partners. The material covered in modules 1-4 is applicable...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for ... care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
direct-acting antiviral (DAA) treatment of adolescents and children ages ≥3 years of age
simplified HCV service delivery (decentralization, integration and task sharing)
HCV diagnostics – use of point-of-care (POC) HCV ribonucleic acid (RNA) assays and reflex HCV RNA testing.
These guidelines also update existing chapters without new recommendations, such as the inclusion of new manufacturers’ protocols on the use of dried blood spot (DBS) for HCV RNA testing and new data to inform the limit of detection for HCV RNA assays as a test of cure, in addition to their use for diagnosis.
